1 Study Coverage
    1.1 Antiemetic Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Antiemetic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Dopamine Antagonist
        1.2.3 5-HT-3 Receptor Antagonist
        1.2.4 NK1 Receptor Antagonist
        1.2.5 Cannabinoid Receptor Antagonist
    1.3 Market by Application
        1.3.1 Global Antiemetic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Chemotherapy
        1.3.3 Gastroenteritis
        1.3.4 Surgery
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Antiemetic Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Antiemetic Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Antiemetic Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Antiemetic Drugs Sales by Region
        2.4.1 Global Antiemetic Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Antiemetic Drugs by Region (2023-2028)
    2.5 Global Antiemetic Drugs Revenue by Region
        2.5.1 Global Antiemetic Drugs Revenue by Region (2017-2022)
        2.5.2 Global Antiemetic Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Antiemetic Drugs Sales by Manufacturers
        3.1.1 Global Top Antiemetic Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Antiemetic Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antiemetic Drugs in 2021
    3.2 Global Antiemetic Drugs Revenue by Manufacturers
        3.2.1 Global Antiemetic Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Antiemetic Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Antiemetic Drugs Revenue in 2021
    3.3 Global Antiemetic Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Antiemetic Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Antiemetic Drugs Sales by Type
        4.1.1 Global Antiemetic Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Antiemetic Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Antiemetic Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Antiemetic Drugs Revenue by Type
        4.2.1 Global Antiemetic Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Antiemetic Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Antiemetic Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Antiemetic Drugs Price by Type
        4.3.1 Global Antiemetic Drugs Price by Type (2017-2022)
        4.3.2 Global Antiemetic Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Antiemetic Drugs Sales by Application
        5.1.1 Global Antiemetic Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Antiemetic Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Antiemetic Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Antiemetic Drugs Revenue by Application
        5.2.1 Global Antiemetic Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Antiemetic Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Antiemetic Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Antiemetic Drugs Price by Application
        5.3.1 Global Antiemetic Drugs Price by Application (2017-2022)
        5.3.2 Global Antiemetic Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Antiemetic Drugs Market Size by Type
        6.1.1 North America Antiemetic Drugs Sales by Type (2017-2028)
        6.1.2 North America Antiemetic Drugs Revenue by Type (2017-2028)
    6.2 North America Antiemetic Drugs Market Size by Application
        6.2.1 North America Antiemetic Drugs Sales by Application (2017-2028)
        6.2.2 North America Antiemetic Drugs Revenue by Application (2017-2028)
    6.3 North America Antiemetic Drugs Market Size by Country
        6.3.1 North America Antiemetic Drugs Sales by Country (2017-2028)
        6.3.2 North America Antiemetic Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Antiemetic Drugs Market Size by Type
        7.1.1 Europe Antiemetic Drugs Sales by Type (2017-2028)
        7.1.2 Europe Antiemetic Drugs Revenue by Type (2017-2028)
    7.2 Europe Antiemetic Drugs Market Size by Application
        7.2.1 Europe Antiemetic Drugs Sales by Application (2017-2028)
        7.2.2 Europe Antiemetic Drugs Revenue by Application (2017-2028)
    7.3 Europe Antiemetic Drugs Market Size by Country
        7.3.1 Europe Antiemetic Drugs Sales by Country (2017-2028)
        7.3.2 Europe Antiemetic Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Antiemetic Drugs Market Size by Type
        8.1.1 Asia Pacific Antiemetic Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Antiemetic Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Antiemetic Drugs Market Size by Application
        8.2.1 Asia Pacific Antiemetic Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Antiemetic Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Antiemetic Drugs Market Size by Region
        8.3.1 Asia Pacific Antiemetic Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Antiemetic Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Antiemetic Drugs Market Size by Type
        9.1.1 Latin America Antiemetic Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Antiemetic Drugs Revenue by Type (2017-2028)
    9.2 Latin America Antiemetic Drugs Market Size by Application
        9.2.1 Latin America Antiemetic Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Antiemetic Drugs Revenue by Application (2017-2028)
    9.3 Latin America Antiemetic Drugs Market Size by Country
        9.3.1 Latin America Antiemetic Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Antiemetic Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Antiemetic Drugs Market Size by Type
        10.1.1 Middle East and Africa Antiemetic Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Antiemetic Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Antiemetic Drugs Market Size by Application
        10.2.1 Middle East and Africa Antiemetic Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Antiemetic Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Antiemetic Drugs Market Size by Country
        10.3.1 Middle East and Africa Antiemetic Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Antiemetic Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Corporation Information
        11.1.2 GlaxoSmithKline Overview
        11.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GlaxoSmithKline Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GlaxoSmithKline Recent Developments
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Corporation Information
        11.2.2 Johnson & Johnson Overview
        11.2.3 Johnson & Johnson Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Johnson & Johnson Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Johnson & Johnson Recent Developments
    11.3 Pfizer
        11.3.1 Pfizer Corporation Information
        11.3.2 Pfizer Overview
        11.3.3 Pfizer Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Pfizer Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Pfizer Recent Developments
    11.4 Sanofi
        11.4.1 Sanofi Corporation Information
        11.4.2 Sanofi Overview
        11.4.3 Sanofi Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Sanofi Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Sanofi Recent Developments
    11.5 Abbott
        11.5.1 Abbott Corporation Information
        11.5.2 Abbott Overview
        11.5.3 Abbott Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Abbott Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Abbott Recent Developments
    11.6 Bristol-Myers Squibb
        11.6.1 Bristol-Myers Squibb Corporation Information
        11.6.2 Bristol-Myers Squibb Overview
        11.6.3 Bristol-Myers Squibb Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Bristol-Myers Squibb Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Bristol-Myers Squibb Recent Developments
    11.7 Cipla
        11.7.1 Cipla Corporation Information
        11.7.2 Cipla Overview
        11.7.3 Cipla Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Cipla Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Cipla Recent Developments
    11.8 Eisai
        11.8.1 Eisai Corporation Information
        11.8.2 Eisai Overview
        11.8.3 Eisai Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Eisai Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Eisai Recent Developments
    11.9 Eli Lilly
        11.9.1 Eli Lilly Corporation Information
        11.9.2 Eli Lilly Overview
        11.9.3 Eli Lilly Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Eli Lilly Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Eli Lilly Recent Developments
    11.10 Glenmark
        11.10.1 Glenmark Corporation Information
        11.10.2 Glenmark Overview
        11.10.3 Glenmark Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Glenmark Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Glenmark Recent Developments
    11.11 Helsinn Healthcare
        11.11.1 Helsinn Healthcare Corporation Information
        11.11.2 Helsinn Healthcare Overview
        11.11.3 Helsinn Healthcare Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Helsinn Healthcare Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Helsinn Healthcare Recent Developments
    11.12 Heron Therapeutics
        11.12.1 Heron Therapeutics Corporation Information
        11.12.2 Heron Therapeutics Overview
        11.12.3 Heron Therapeutics Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Heron Therapeutics Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Heron Therapeutics Recent Developments
    11.13 IPCA Laboratories
        11.13.1 IPCA Laboratories Corporation Information
        11.13.2 IPCA Laboratories Overview
        11.13.3 IPCA Laboratories Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 IPCA Laboratories Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 IPCA Laboratories Recent Developments
    11.14 Lupin
        11.14.1 Lupin Corporation Information
        11.14.2 Lupin Overview
        11.14.3 Lupin Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Lupin Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Lupin Recent Developments
    11.15 Merck
        11.15.1 Merck Corporation Information
        11.15.2 Merck Overview
        11.15.3 Merck Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Merck Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Merck Recent Developments
    11.16 Novartis
        11.16.1 Novartis Corporation Information
        11.16.2 Novartis Overview
        11.16.3 Novartis Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Novartis Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Novartis Recent Developments
    11.17 RedHill
        11.17.1 RedHill Corporation Information
        11.17.2 RedHill Overview
        11.17.3 RedHill Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 RedHill Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 RedHill Recent Developments
    11.18 Sun Pharmaceutical Industries
        11.18.1 Sun Pharmaceutical Industries Corporation Information
        11.18.2 Sun Pharmaceutical Industries Overview
        11.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.18.4 Sun Pharmaceutical Industries Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Sun Pharmaceutical Industries Recent Developments
    11.19 Takeda Pharmaceutical
        11.19.1 Takeda Pharmaceutical Corporation Information
        11.19.2 Takeda Pharmaceutical Overview
        11.19.3 Takeda Pharmaceutical Antiemetic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.19.4 Takeda Pharmaceutical Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.19.5 Takeda Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Antiemetic Drugs Industry Chain Analysis
    12.2 Antiemetic Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Antiemetic Drugs Production Mode & Process
    12.4 Antiemetic Drugs Sales and Marketing
        12.4.1 Antiemetic Drugs Sales Channels
        12.4.2 Antiemetic Drugs Distributors
    12.5 Antiemetic Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Antiemetic Drugs Industry Trends
    13.2 Antiemetic Drugs Market Drivers
    13.3 Antiemetic Drugs Market Challenges
    13.4 Antiemetic Drugs Market Restraints
14 Key Findings in The Global Antiemetic Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Antiemetic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Dopamine Antagonist
    Table 3. Major Manufacturers of 5-HT-3 Receptor Antagonist
    Table 4. Major Manufacturers of NK1 Receptor Antagonist
    Table 5. Major Manufacturers of Cannabinoid Receptor Antagonist
    Table 6. Global Antiemetic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Antiemetic Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Antiemetic Drugs Sales by Region (2017-2022) & (K Units)
    Table 9. Global Antiemetic Drugs Sales Market Share by Region (2017-2022)
    Table 10. Global Antiemetic Drugs Sales by Region (2023-2028) & (K Units)
    Table 11. Global Antiemetic Drugs Sales Market Share by Region (2023-2028)
    Table 12. Global Antiemetic Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Antiemetic Drugs Revenue Market Share by Region (2017-2022)
    Table 14. Global Antiemetic Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Antiemetic Drugs Revenue Market Share by Region (2023-2028)
    Table 16. Global Antiemetic Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Antiemetic Drugs Sales Share by Manufacturers (2017-2022)
    Table 18. Global Antiemetic Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Antiemetic Drugs Revenue Share by Manufacturers (2017-2022)
    Table 20. Antiemetic Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Antiemetic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Antiemetic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiemetic Drugs as of 2021)
    Table 23. Antiemetic Drugs Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Antiemetic Drugs Product Offered
    Table 25. Date of Manufacturers Enter into Antiemetic Drugs Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
    Table 28. Global Antiemetic Drugs Sales by Type (2023-2028) & (K Units)
    Table 29. Global Antiemetic Drugs Sales Share by Type (2017-2022)
    Table 30. Global Antiemetic Drugs Sales Share by Type (2023-2028)
    Table 31. Global Antiemetic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Antiemetic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Antiemetic Drugs Revenue Share by Type (2017-2022)
    Table 34. Global Antiemetic Drugs Revenue Share by Type (2023-2028)
    Table 35. Antiemetic Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Antiemetic Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
    Table 38. Global Antiemetic Drugs Sales by Application (2023-2028) & (K Units)
    Table 39. Global Antiemetic Drugs Sales Share by Application (2017-2022)
    Table 40. Global Antiemetic Drugs Sales Share by Application (2023-2028)
    Table 41. Global Antiemetic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Antiemetic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Antiemetic Drugs Revenue Share by Application (2017-2022)
    Table 44. Global Antiemetic Drugs Revenue Share by Application (2023-2028)
    Table 45. Antiemetic Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Antiemetic Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
    Table 48. North America Antiemetic Drugs Sales by Type (2023-2028) & (K Units)
    Table 49. North America Antiemetic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Antiemetic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
    Table 52. North America Antiemetic Drugs Sales by Application (2023-2028) & (K Units)
    Table 53. North America Antiemetic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Antiemetic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
    Table 56. North America Antiemetic Drugs Sales by Country (2023-2028) & (K Units)
    Table 57. North America Antiemetic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Antiemetic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Antiemetic Drugs Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Antiemetic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Antiemetic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Antiemetic Drugs Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Antiemetic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Antiemetic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Antiemetic Drugs Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Antiemetic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Antiemetic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Antiemetic Drugs Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Antiemetic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Antiemetic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Antiemetic Drugs Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Antiemetic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Antiemetic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Antiemetic Drugs Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Antiemetic Drugs Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Antiemetic Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Antiemetic Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Antiemetic Drugs Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Antiemetic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Antiemetic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Antiemetic Drugs Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Antiemetic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Antiemetic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Antiemetic Drugs Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Antiemetic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Antiemetic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Antiemetic Drugs Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Antiemetic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Antiemetic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Antiemetic Drugs Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Antiemetic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Antiemetic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Antiemetic Drugs Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Antiemetic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Antiemetic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 107. GlaxoSmithKline Corporation Information
    Table 108. GlaxoSmithKline Description and Major Businesses
    Table 109. GlaxoSmithKline Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. GlaxoSmithKline Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. GlaxoSmithKline Recent Developments
    Table 112. Johnson & Johnson Corporation Information
    Table 113. Johnson & Johnson Description and Major Businesses
    Table 114. Johnson & Johnson Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Johnson & Johnson Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Johnson & Johnson Recent Developments
    Table 117. Pfizer Corporation Information
    Table 118. Pfizer Description and Major Businesses
    Table 119. Pfizer Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Pfizer Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Pfizer Recent Developments
    Table 122. Sanofi Corporation Information
    Table 123. Sanofi Description and Major Businesses
    Table 124. Sanofi Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Sanofi Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Sanofi Recent Developments
    Table 127. Abbott Corporation Information
    Table 128. Abbott Description and Major Businesses
    Table 129. Abbott Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Abbott Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Abbott Recent Developments
    Table 132. Bristol-Myers Squibb Corporation Information
    Table 133. Bristol-Myers Squibb Description and Major Businesses
    Table 134. Bristol-Myers Squibb Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Bristol-Myers Squibb Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Bristol-Myers Squibb Recent Developments
    Table 137. Cipla Corporation Information
    Table 138. Cipla Description and Major Businesses
    Table 139. Cipla Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. Cipla Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Cipla Recent Developments
    Table 142. Eisai Corporation Information
    Table 143. Eisai Description and Major Businesses
    Table 144. Eisai Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. Eisai Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Eisai Recent Developments
    Table 147. Eli Lilly Corporation Information
    Table 148. Eli Lilly Description and Major Businesses
    Table 149. Eli Lilly Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. Eli Lilly Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Eli Lilly Recent Developments
    Table 152. Glenmark Corporation Information
    Table 153. Glenmark Description and Major Businesses
    Table 154. Glenmark Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 155. Glenmark Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Glenmark Recent Developments
    Table 157. Helsinn Healthcare Corporation Information
    Table 158. Helsinn Healthcare Description and Major Businesses
    Table 159. Helsinn Healthcare Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 160. Helsinn Healthcare Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Helsinn Healthcare Recent Developments
    Table 162. Heron Therapeutics Corporation Information
    Table 163. Heron Therapeutics Description and Major Businesses
    Table 164. Heron Therapeutics Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 165. Heron Therapeutics Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Heron Therapeutics Recent Developments
    Table 167. IPCA Laboratories Corporation Information
    Table 168. IPCA Laboratories Description and Major Businesses
    Table 169. IPCA Laboratories Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 170. IPCA Laboratories Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. IPCA Laboratories Recent Developments
    Table 172. Lupin Corporation Information
    Table 173. Lupin Description and Major Businesses
    Table 174. Lupin Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 175. Lupin Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. Lupin Recent Developments
    Table 177. Merck Corporation Information
    Table 178. Merck Description and Major Businesses
    Table 179. Merck Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 180. Merck Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 181. Merck Recent Developments
    Table 182. Novartis Corporation Information
    Table 183. Novartis Description and Major Businesses
    Table 184. Novartis Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 185. Novartis Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 186. Novartis Recent Developments
    Table 187. RedHill Corporation Information
    Table 188. RedHill Description and Major Businesses
    Table 189. RedHill Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 190. RedHill Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 191. RedHill Recent Developments
    Table 192. Sun Pharmaceutical Industries Corporation Information
    Table 193. Sun Pharmaceutical Industries Description and Major Businesses
    Table 194. Sun Pharmaceutical Industries Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 195. Sun Pharmaceutical Industries Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 196. Sun Pharmaceutical Industries Recent Developments
    Table 197. Takeda Pharmaceutical Corporation Information
    Table 198. Takeda Pharmaceutical Description and Major Businesses
    Table 199. Takeda Pharmaceutical Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 200. Takeda Pharmaceutical Antiemetic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 201. Takeda Pharmaceutical Recent Developments
    Table 202. Key Raw Materials Lists
    Table 203. Raw Materials Key Suppliers Lists
    Table 204. Antiemetic Drugs Distributors List
    Table 205. Antiemetic Drugs Customers List
    Table 206. Antiemetic Drugs Market Trends
    Table 207. Antiemetic Drugs Market Drivers
    Table 208. Antiemetic Drugs Market Challenges
    Table 209. Antiemetic Drugs Market Restraints
    Table 210. Research Programs/Design for This Report
    Table 211. Key Data Information from Secondary Sources
    Table 212. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antiemetic Drugs Product Picture
    Figure 3. Global Antiemetic Drugs Market Share by Type in 2021 & 2028
    Figure 3. Dopamine Antagonist Product Picture
    Figure 4. 5-HT-3 Receptor Antagonist Product Picture
    Figure 5. NK1 Receptor Antagonist Product Picture
    Figure 6. Cannabinoid Receptor Antagonist Product Picture
    Figure 7. Global Antiemetic Drugs Market Share by Application in 2021 & 2028
    Figure 8. Chemotherapy
    Figure 9. Gastroenteritis
    Figure 10. Surgery
    Figure 11. Antiemetic Drugs Report Years Considered
    Figure 12. Global Antiemetic Drugs Sales 2017-2028 (K Units)
    Figure 13. Global Antiemetic Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Antiemetic Drugs Revenue 2017-2028 (US$ Million)
    Figure 15. Global Antiemetic Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Antiemetic Drugs Sales Market Share by Region (2017-2022)
    Figure 17. Global Antiemetic Drugs Sales Market Share by Region (2023-2028)
    Figure 18. North America Antiemetic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Antiemetic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Antiemetic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Antiemetic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Antiemetic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Antiemetic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Antiemetic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Antiemetic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Antiemetic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Antiemetic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Antiemetic Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Antiemetic Drugs in the World: Market Share by Antiemetic Drugs Revenue in 2021
    Figure 30. Global Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Antiemetic Drugs Sales Market Share by Type (2017-2028)
    Figure 32. Global Antiemetic Drugs Revenue Market Share by Type (2017-2028)
    Figure 33. Global Antiemetic Drugs Sales Market Share by Application (2017-2028)
    Figure 34. Global Antiemetic Drugs Revenue Market Share by Application (2017-2028)
    Figure 35. North America Antiemetic Drugs Sales Market Share by Type (2017-2028)
    Figure 36. North America Antiemetic Drugs Revenue Market Share by Type (2017-2028)
    Figure 37. North America Antiemetic Drugs Sales Market Share by Application (2017-2028)
    Figure 38. North America Antiemetic Drugs Revenue Market Share by Application (2017-2028)
    Figure 39. North America Antiemetic Drugs Sales Share by Country (2017-2028)
    Figure 40. North America Antiemetic Drugs Revenue Share by Country (2017-2028)
    Figure 41. U.S. Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Antiemetic Drugs Sales Market Share by Type (2017-2028)
    Figure 44. Europe Antiemetic Drugs Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Antiemetic Drugs Sales Market Share by Application (2017-2028)
    Figure 46. Europe Antiemetic Drugs Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Antiemetic Drugs Sales Share by Country (2017-2028)
    Figure 48. Europe Antiemetic Drugs Revenue Share by Country (2017-2028)
    Figure 49. Germany Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. France Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Antiemetic Drugs Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Antiemetic Drugs Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Antiemetic Drugs Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Antiemetic Drugs Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Antiemetic Drugs Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Antiemetic Drugs Revenue Share by Region (2017-2028)
    Figure 60. China Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. India Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Antiemetic Drugs Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Antiemetic Drugs Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Antiemetic Drugs Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Antiemetic Drugs Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Antiemetic Drugs Sales Share by Country (2017-2028)
    Figure 75. Latin America Antiemetic Drugs Revenue Share by Country (2017-2028)
    Figure 76. Mexico Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Antiemetic Drugs Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Antiemetic Drugs Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Antiemetic Drugs Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Antiemetic Drugs Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Antiemetic Drugs Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Antiemetic Drugs Revenue Share by Country (2017-2028)
    Figure 85. Turkey Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Antiemetic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 88. Antiemetic Drugs Value Chain
    Figure 89. Antiemetic Drugs Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed